Open AccessPredictors of failure of fish-oil therapy for intestinal failure–associated liver disease in children,
Author(s) -
Prathima Nandivada,
Meredith A. Baker,
Paul D. Mitchell,
Alison A. O’Loughlin,
Alexis K. Potemkin,
Lorenzo AnezBustillos,
Sarah J. Carlson,
Duy T. Dao,
Gillian L. Fell,
Kathleen M. Gura,
Mark Puder
Publication year - 2016
Publication title -
american journal of clinical nutrition
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.608
H-Index - 336
eISSN - 1938-3207
pISSN - 0002-9165
DOI - 10.3945/ajcn.116.137083
Subject(s) - medicine , cholestasis , liver disease , gastroenterology , liver transplantation , surgery , transplantation
Parenteral fish-oil (FO) therapy is a safe and effective treatment for intestinal failure-associated liver disease (IFALD). Patients whose cholestasis does not resolve with FO may progress to end-stage liver disease.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom